Sex-Associated Differences in Cytomegalovirus Prevention: Prophylactic Strategy is Potentially Associated With a Strong Kidney Function Impairment in Female Renal Transplant Patients
- Sprache
-
Englisch
- Identifier
-
1272770680
Beteiligte Personen und Organisationen
Blazquez-Navarro, Arturo
Dang-Heine, Chantip
Bauer, Chris
Wittenbrink, Nicole
Wolk, Kerstin
Sabat, Robert
Witzke, Oliver
Westhoff, Timm H.
Sawitzki, Birgit
Reinke, Petra
Thomusch, Oliver
Hugo, Christian
Babel, Nina
Or-Guil, Michal
Dang-Heine, Chantip
Bauer, Chris
Wittenbrink, Nicole
Wolk, Kerstin
Sabat, Robert
Witzke, Oliver
Westhoff, Timm H.
Sawitzki, Birgit
Reinke, Petra
Thomusch, Oliver
Hugo, Christian
Babel, Nina
Or-Guil, Michal
- DOI
-
10.3389/fphar.2020.534681
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
28.02.2023, 11:39 MEZ
Beteiligte
- Blazquez-Navarro, Arturo
- Dang-Heine, Chantip
- Bauer, Chris
- Wittenbrink, Nicole
- Wolk, Kerstin
- Sabat, Robert
- Witzke, Oliver
- Westhoff, Timm H.
- Sawitzki, Birgit
- Reinke, Petra
- Thomusch, Oliver
- Hugo, Christian
- Babel, Nina
- Or-Guil, Michal
Ähnliche Objekte (12)
Sex-associated differences in cytomegalovirus prevention: prophylactic strategy is potentially associated with a strong kidney function impairment in female renal transplant patients
A novel approach reveals that HLA class 1 single antigen bead-signatures provide a means of high-accuracy pre-transplant risk assessment of acute cellular rejection in renal transplantation
Risk factors for Epstein–Barr virus reactivation after renal transplantation: Results of a large, multi‐centre study
The role of soluble mediators in the clinical course of EBV infection and B cell homeostasis after kidney transplantation
Differential T cell response against BK virus regulatory and structural antigens: a viral dynamics modelling approach
Effect of plasma exchange on COVID-19 associated excess of von Willebrand factor and inflammation in critically ill patients
Effects of treatment of asymptomatic hyperuricemia on graft survival and mortality in kidney transplant recipients
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus : an analysis from the randomized ZEUS study
Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination
Reactivations of Latent Viral Infections Are Associated with an Increased Thr389 p70S6k Phosphorylation in Peripheral Lymphocytes of Renal Transplant Recipients
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study
CD107a+ (LAMP-1) Cytotoxic CD8+ T-Cells in Lupus Nephritis Patients
Sex-associated differences in cytomegalovirus prevention: prophylactic strategy is potentially associated with a strong kidney function impairment in female renal transplant patients
A novel approach reveals that HLA class 1 single antigen bead-signatures provide a means of high-accuracy pre-transplant risk assessment of acute cellular rejection in renal transplantation
Risk factors for Epstein–Barr virus reactivation after renal transplantation: Results of a large, multi‐centre study
The role of soluble mediators in the clinical course of EBV infection and B cell homeostasis after kidney transplantation
Differential T cell response against BK virus regulatory and structural antigens: a viral dynamics modelling approach
Effect of plasma exchange on COVID-19 associated excess of von Willebrand factor and inflammation in critically ill patients
Effects of treatment of asymptomatic hyperuricemia on graft survival and mortality in kidney transplant recipients
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus : an analysis from the randomized ZEUS study
Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination
Reactivations of Latent Viral Infections Are Associated with an Increased Thr389 p70S6k Phosphorylation in Peripheral Lymphocytes of Renal Transplant Recipients
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study
CD107a+ (LAMP-1) Cytotoxic CD8+ T-Cells in Lupus Nephritis Patients
Sex-associated differences in cytomegalovirus prevention: prophylactic strategy is potentially associated with a strong kidney function impairment in female renal transplant patients
A novel approach reveals that HLA class 1 single antigen bead-signatures provide a means of high-accuracy pre-transplant risk assessment of acute cellular rejection in renal transplantation
Risk factors for Epstein–Barr virus reactivation after renal transplantation: Results of a large, multi‐centre study
The role of soluble mediators in the clinical course of EBV infection and B cell homeostasis after kidney transplantation
Differential T cell response against BK virus regulatory and structural antigens: a viral dynamics modelling approach
Effect of plasma exchange on COVID-19 associated excess of von Willebrand factor and inflammation in critically ill patients
Effects of treatment of asymptomatic hyperuricemia on graft survival and mortality in kidney transplant recipients
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus : an analysis from the randomized ZEUS study
Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination
Reactivations of Latent Viral Infections Are Associated with an Increased Thr389 p70S6k Phosphorylation in Peripheral Lymphocytes of Renal Transplant Recipients
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study